NPS

0.225

(%)

Half yearly rpt on consolidated results for the financial period ended 31 Dec 2023

NOVA PHARMA SOLUTIONS BERHAD

Financial Year End 31 Dec 2023
Half Year 2 H
Half yearly report for the financial period ended 31 Dec 2023
The figures have not been audited

Attachments

NPS 2nd Half 2023 report.pdf
442.3 kB

  • Default Currency
  • Other Currency

Currency: Malaysian Ringgit (MYR)

SUMMARY OF KEY FINANCIAL INFORMATION
Half Year ended 31 Dec 2023

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR
Half Year
PRECEDING YEAR
CORRESPONDING
Half Year
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
31 Dec 2023
31 Dec 2022
31 Dec 2023
31 Dec 2022
$$'000
$$'000
$$'000
$$'000
1 Revenue
4,994
3,574
10,379
7,245
2 Profit/(loss) before tax
2,295
323
5,004
1,443
3 Profit/(loss) for the period
1,834
257
3,941
1,167
4 Profit/(loss) attributable to ordinary equity holders of the parent
1,834
257
3,941
1,167
5 Basic earnings/(loss) per share (Subunit)
1.23
0.17
2.64
0.78
6 Proposed/Declared dividend per share (Subunit)
0.00
0.00
0.00
0.00


AS AT END OF CURRENT
Half Yearly Report
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($$)
0.0960
0.0750

Definition of Subunit:

In a currency system, there is usually a main unit (base) and subunit that is a fraction amount of the main unit.
Example for the subunit as follows:

Country Base Unit Subunit
Malaysia Ringgit Sen
United States Dollar Cent
United Kingdom Pound Pence




Announcement Info

Company Name NOVA PHARMA SOLUTIONS BERHAD
Stock Name NPS
Date Announced 22 Feb 2024
Category Financial Results
Reference Number FRA-20022024-00030